|FOIFF -- USA Stock|| |
null 0.33 0.00 0.00%
Co-Founder, Chief Science Officer and Member of Scientific Advisory Board
We currently do not have informatin regarding Daniel Muruve. This executive tanure with Arch Biopartners is not currenlty determined.
Founder Since 2013
The company has return on total asset (ROA)
of (85.15) %
which means that it has lost $85.15 on every $100 spent on asset. This is way below average.
The company has accumulated 246.87 K in total debt. Arch Biopartners has Current Ratio of 2.71 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Arch Biopartners, Inc., a biotechnology company, develops solutions and technologies for medical use. Arch Biopartners (FOIFF) is traded on OTC Market in USA. It is located in Arch Biopartners, Inc.Toronto, ON MV M and employs 9 people.
Arch Biopartners Leadership Team
|Conor Gunne, Director|
|Richard Rossman, Director|
|Andrew Bishop, Director, MBA|
|Claude Allary, Director|
|Daniel Muruve, Founder|
|Richard Muruve, CEO, MBA|
|Patrick Vink, Director|
|Adrian Haigh, Director|
Stock Performance Indicators